Lung microbiology and exacerbations in COPD

References

• AustrianRThe bacterial flora of the respiratory tract. Some knowns and unknownsYale J Biol Med1968404004135302612
   PubMed Web of Science ®Google Scholar
• RosellAMonsoESolerNMicrobiologic determinants of exacerbation in chronic obstructive pulmonary diseaseArch Intern Med200516589189715851640
   PubMed Web of Science ®Google Scholar
• WeinreichUMKorsgaardJBacterial colonisation of lower airways in health and chronic lung diseaseClin Respir J2008211612220298316
   PubMed Web of Science ®Google Scholar
• SethiSMaloneyJGroveLWronaCBerensonCSAirway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200617399199816474030
   PubMed Web of Science ®Google Scholar
• ZalacainRSobradilloVAmilibiaJPredisposing factors to bacterial colonization in chronic obstructive pulmonary diseaseEur Respir J19991334334810065679
   PubMed Web of Science ®Google Scholar
• HillATCampbellEJHillSLBayleyDLStockleyRAAssociation between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitisAm J Med200010928829510996579
   PubMed Web of Science ®Google Scholar
• MonsoERosellABonetGRisk factors for lower airway bacterial colonization in chronic bronchitisEur Respir J19991333834210065678
   PubMed Web of Science ®Google Scholar
• SolerNEwigSTorresAFilellaXGonzalezJZaubetAAirway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary diseaseEur Respir J1999141015102210596683
   PubMed Web of Science ®Google Scholar
• PatelISSeemungalTAWilksMLloyd-OwenSJDonaldsonGCWedzichaJARelationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbationsThorax20025775976412200518
   PubMed Web of Science ®Google Scholar
• WilkinsonTMPatelISWilksMDonaldsonGCWedzichaJAAirway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20031671090109512684248
   PubMed Web of Science ®Google Scholar
• HurstJRWilkinsonTMPereraWRDonaldsonGCWedzichaJARelationships among bacteria, upper airway, lower airway, and systemic inflammation in COPDChest20051271219122615821198
   PubMed Web of Science ®Google Scholar
• EnglerKMuhlemannKGarzoniCPfahlerHGeiserTvon GarnierCColonisation with Pseudomonas aeruginosa and antibiotic resistance patterns in COPD patientsSwiss Med Wkly2012142010.4414/smw.2012.1350922290607
   PubMed Web of Science ®Google Scholar
• MurphyTFBrauerALEschbergerKPseudomonas aeruginosa in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200817785386018202344
   PubMed Web of Science ®Google Scholar
• MiravitllesMEspinosaCFernandez-LasoEMartosJAMaldonadoJAGallegoMRelationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPDChest1999116404610424501
   PubMed Web of Science ®Google Scholar
• EllerJEdeASchabergTNiedermanMSMauchHLodeHInfective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung functionChest1998113154215489631791
   PubMed Web of Science ®Google Scholar
• LodeHAlleweltMBalkSA prediction model for bacterial etiology in acute exacerbations of COPDInfection20073514314917565454
   PubMed Web of Science ®Google Scholar
• SuauABonnetRSutrenMDirect analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gutAppl Environ Microbiol1999654799480710543789
   PubMed Web of Science ®Google Scholar
• LaneDJPaceBOlsenGJStahlDASoginMLPaceNRRapid determination of 16S ribosomal RNA sequences for phylogenetic analysesProc Natl Acad Sci U S A198582695569592413450
   PubMed Web of Science ®Google Scholar
• HiltyMBurkeCPedroHDisordered microbial communities in asthmatic airwaysPLoS ONE20105e857820052417
   PubMed Web of Science ®Google Scholar
• Erb-DownwardJRThompsonDLHanMKAnalysis of the lung microbiome in the “healthy” smoker and in COPDPLoS One20116e1638421364979
   PubMed Web of Science ®Google Scholar
• SzeMADimitriuPAHayashiSThe lung tissue microbiome in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185101073108022427533
   PubMed Web of Science ®Google Scholar
• CharlsonESChenJCusters-AllenRDisordered microbial communities in the upper respiratory tract of cigarette smokersPLoS One20105e1521621188149
   PubMed Web of Science ®Google Scholar
• OttSJMusfeldtMWenderothDFReduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel diseaseGut20045368569315082587
   PubMed Web of Science ®Google Scholar
• HuangYJKimECoxMJA persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbationsOMICS20101495920141328
   PubMed Web of Science ®Google Scholar
• HanMKHuangYJLipumaJJSignificance of the microbiome in obstructive lung diseaseThorax20126745646322318161
   PubMed Web of Science ®Google Scholar
• BanerjeeDKhairOAHoneybourneDImpact of sputum bacteria on airway inflammation and health status in clinical stable COPDEur Respir J20042368569115176680
   PubMed Web of Science ®Google Scholar
• MarinAMonsoEGarcia-NunezMVariability and effects of bronchial colonisation in patients with moderate COPDEur Respir J20103529530219643939
   PubMed Web of Science ®Google Scholar
• BresserPOutTAvan AlphenLJansenHMLutterRAirway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200016294795210988111
   PubMed Web of Science ®Google Scholar
• MarinAGarcia-AymerichJSauledaJPAC-COPD Study GroupEffect of Bronchial Colonisation on Airway and Systemic Inflammation in Stable COPDCOPD2012912113022458940
   PubMedGoogle Scholar
• BogaertDvan der ValkPRamdinRHost-pathogen interaction during pneumococcal infection in patients with chronic obstructive pulmonary diseaseInfect Immun20047281882314742525
   PubMed Web of Science ®Google Scholar
• ParameswaranGIWronaCTMurphyTFSethiSMoraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary diseaseBMC Infect Dis2009917819912665
   PubMed Web of Science ®Google Scholar
• KnoblochJSchildKJungckDThe T-helper cell type 1 immune response to gram-negative bacterial infections is impaired in COPDAm J Respir Crit Care Med201118320421420709824
   PubMed Web of Science ®Google Scholar
• MehtaHNazzalKSadikotRTCigarette smoking and innate immunityInflamm Res20085749750319109742
   PubMed Web of Science ®Google Scholar
• CurrieDCPaviaDAgnewJEImpaired tracheobronchial clearance in bronchiectasisThorax1987421261303433236
   PubMed Web of Science ®Google Scholar
• VerraFEscudierELebargyFBernaudinJFDeCHBignonJCiliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokersAm J Respir Crit Care Med19951516306347881648
   PubMed Web of Science ®Google Scholar
• OliveraDSBoggsSEBeenhouwerCAdenJKnallCCellular mechanisms of mainstream cigarette smoke-induced lung epithelial tight junction permeability changes in vitroInhal Toxicol200719132217127639
   PubMed Web of Science ®Google Scholar
• TaylorAEFinney-HaywardTKQuintJKDefective macrophage phagocytosis of bacteria in COPDEur Respir J2009
   Web of Science ®Google Scholar
• Marti-LliterasPRegueiroVMoreyPNontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smokeInfect Immun2009774232424219620348
   PubMed Web of Science ®Google Scholar
• HodgeSHodgeGAhernJJersmannHHolmesMReynoldsPNSmoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol20073774875517630319
   PubMed Web of Science ®Google Scholar
• LofdahlJMWahlstromJSkoldCMDifferent inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokersClin Exp Immunol200614542843716907910
   PubMed Web of Science ®Google Scholar
• BerensonCSGarlippMAGroveLJMaloneyJSethiSImpaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary diseaseJ Infect Dis20061941375138417054066
   PubMed Web of Science ®Google Scholar
• HodgeSReynoldsPNLow-dose Azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin COPD subjectsRespirology20121780280722288725
   PubMed Web of Science ®Google Scholar
• DroemannDGoldmannTTiedjeTZabelPDalhoffKSchaafBToll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patientsRespir Res200566816004610
   PubMed Web of Science ®Google Scholar
• von ScheeleILarssonKDahlénBToll-like receptor expression in smokers with and without COPDRespir Med20111051222123021439805
   PubMed Web of Science ®Google Scholar
• ElomaaOSankalaMPikkarainenTStructure of the human macrophage MARCO receptor and characterization of its bacteria-binding regionJ Biol Chem1998273453045389468508
   PubMed Web of Science ®Google Scholar
• BaqirMChenCZMartinRJCigarette smoke decreases MARCO expression in macrophages: implication in Mycoplasma pneumoniae infectionRespir Med20081021604161018590957
   PubMed Web of Science ®Google Scholar
• HarveyCJThimmulappaRKSethiSTargeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse modelSci Transl Med2011378ra32
   PubMed Web of Science ®Google Scholar
• HodgeSHodgeGJersmannHAzithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200817813914818420960
   PubMed Web of Science ®Google Scholar
• HodgeSHodgeGBrozynaSJersmannHHolmesMReynoldsPNAzithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophagesEur Respir J20062848649516737992
   PubMed Web of Science ®Google Scholar
• AndresenEGuntherGBullwinkelJLangeCHeineHIncreased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary diseasePLoS ONE20116e2189821818276
   PubMed Web of Science ®Google Scholar
• PaceEFerraroMMinerviniMIBeta defensin-2 is reduced in central but not in distal airways of smoker COPD PatientsPLoS ONE20127e3360122438960
   PubMed Web of Science ®Google Scholar
• TsoumakidouMBouloukakiIThimakiKTzanakisNSiafakasNMInnate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosisExp Lung Res20103637338020653472
   PubMed Web of Science ®Google Scholar
• PaoneGContiVLeoneAHuman neutrophil peptides sputum levels in symptomatic smokers and COPD patientsEur Rev Med Pharmacol Sci20111555656221744752
   PubMed Web of Science ®Google Scholar
• GrieseMLatzinPKapplerMalpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patientsEur Respir J20072924025017050563
   PubMed Web of Science ®Google Scholar
• ZhouXShapiroLFellinghamGWillardsonBMBurtonGFHIV replication in CD4+ T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by alpha-1- antitrypsin through altered IkappaBalpha ubiquitinationJ Immunol20111863148315521263074
   PubMed Web of Science ®Google Scholar
• DowsonLJGuestPJStockleyRAThe relationship of chronic sputum expectoration to physiologic, radiologic, and health status characteristics in alpha(1)-antitrypsin deficiency (PiZ)Chest20021221247125512377849
   PubMed Web of Science ®Google Scholar
• StevensonCSBirrellMAMoving towards a new generation of animal models for asthma and COPD with improved clinical relevancePharmacol Ther20111309310521074553
   PubMed Web of Science ®Google Scholar
• WrightJLCosioMChurgAAnimal models of chronic obstructive pulmonary diseaseAm J Physiol Lung Cell Mol Physiol2008295L1L1518456796
   PubMed Web of Science ®Google Scholar
• GaschlerGJSkrticMZavitzCCBacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profileAm J Respir Crit Care Med200917966667519179487
   PubMed Web of Science ®Google Scholar
• DrannikAGPouladiMARobbinsCSGoncharovaSIKianpourSStampfliMRImpact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infectionAm J Respir Crit Care Med20041701164117115317669
   PubMed Web of Science ®Google Scholar
• ChurgASinDDWrightJLEverything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use?Am J Respir Cell Mol Biol2011451111111521685155
   PubMed Web of Science ®Google Scholar
• PangBHongWWest-BarnetteSLKockNDSwordsWEDiminished ICAM-1 expression and impaired pulmonary clearance of nontypeable Haemophilus influenzae in a mouse model of chronic obstructive pulmonary disease/emphysemaInfect Immun2008764959496718794286
   PubMed Web of Science ®Google Scholar
• GanesanSFarisANComstockATSonsteinJCurtisJLSajjanUSElastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge: role of scavenger receptor AAm J Pathol2012180617222079429
   PubMed Web of Science ®Google Scholar
• ArredouaniMSYangZImrichANingYQinGKobzikLThe macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particlesAm J Respir Cell Mol Biol20063547447816675784
   PubMed Web of Science ®Google Scholar
• OharJAHamiltonRFJrZhengSCOPD is associated with a macrophage scavenger receptor-1 gene sequence variationChest20101371098110720081102
   PubMed Web of Science ®Google Scholar
• WangDWangYLiuYNExperimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamstersPulm Pharmacol Ther20102329229920211751
   PubMed Web of Science ®Google Scholar
• HirschmannJVDo bacteria cause exacerbations of COPD?Chest200011819320310893379
   PubMed Web of Science ®Google Scholar
• WilkinsonTMHurstJRPereraWRWilksMDonaldsonGCWedzichaJAEffect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPDChest200612931732416478847
   PubMed Web of Science ®Google Scholar
• HurstJRPereraWRWilkinsonTMDonaldsonGCWedzichaJASystemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2006173717816179639
   PubMed Web of Science ®Google Scholar
• PapiABellettatoCMBraccioniFInfections and airway inflammation in chronic obstructive pulmonary disease severe exacerbationsAm J Respir Crit Care Med20061731114112116484677
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med201118466267121680942
   PubMed Web of Science ®Google Scholar
• SethiSEvansNGrantBJMurphyTFNew strains of bacteria and exacerbations of chronic obstructive pulmonary diseaseN Engl J Med200234746547112181400
   PubMed Web of Science ®Google Scholar
• SethiSSethiREschbergerKAirway bacterial concentrations and exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200717635636117478618
   PubMed Web of Science ®Google Scholar
• MurphyTFBrauerALSethiSKilianMCaiXLesseAJHaemophilus haemolyticus: a human respiratory tract commensal to be distinguished from Haemophilus influenzaeJ Infect Dis2007195818917152011
   PubMed Web of Science ®Google Scholar
• MurphyTFBrauerALGrantBJSethiSMoraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune responseAm J Respir Crit Care Med200517219519915805178
   PubMed Web of Science ®Google Scholar
• SethiSWronaCEschbergerKLobbinsPCaiXMurphyTFInflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200817749149718079493
   PubMed Web of Science ®Google Scholar
• ChinCLManzelLJLehmanEEHaemophilus influenzae from patients with chronic obstructive pulmonary disease exacerbation induce more inflammation than colonizersAm J Respir Crit Care Med2005172859115805181
   PubMed Web of Science ®Google Scholar
• JenkinsCRCelliBAndersonJASeasonality and determinants of moderate and severe COPD exacerbations in the TORCH studyEur Respir J201239384521737561
   PubMed Web of Science ®Google Scholar
• SeemungalTHarper-OwenRBhowmikARespiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20011641618162311719299
   PubMed Web of Science ®Google Scholar
• SmithCBGoldenCAKannerRERenzettiADJrAssociation of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseasesAm Rev Respir Dis19801212252326244766
   PubMed Web of Science ®Google Scholar
• BuschoROSaxtanDShultzPSFinchEMufsonMAInfections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitisJ Infect Dis1978137377383206630
   PubMed Web of Science ®Google Scholar
• RohdeGWiethegeABorgIRespiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control studyThorax200358374212511718
   PubMed Web of Science ®Google Scholar
• QiuYZhuJBandiVBiopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200316896897512857718
   PubMed Web of Science ®Google Scholar
• TanWCXiangXQiuDNgTPLamSFHegeleRGEpidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary diseaseAm J Med200311527227712967691
   PubMed Web of Science ®Google Scholar
• CameronRJde WitDWelshTNFergusonJGrissellTVRyePJVirus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilationIntensive Care Med2006321022102916791664
   PubMed Web of Science ®Google Scholar
• MohanAChandraSAgarwalDPrevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic reviewRespirology20101553654220415983
   PubMed Web of Science ®Google Scholar
• SinghMLeeSHPorterPHuman rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary diseaseJ Allergy Clin Immunol20101251369137820430426
   PubMed Web of Science ®Google Scholar
• MessageSDLaza-StancaVMalliaPRhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 productionProc Natl Acad Sci U S A2008105135621356718768794
   PubMed Web of Science ®Google Scholar
• ContoliMMessageSDLaza-StancaVRole of deficient type III interferon-lambda production in asthma exacerbationsNat Med2006121023102616906156
   PubMed Web of Science ®Google Scholar
• MalliaPMessageSDGielenVExperimental Rhinovirus Infection as a Human Model of Chronic Obstructive Pulmonary Disease ExacerbationAm J Respir Crit Care Med201118373474220889904
   PubMed Web of Science ®Google Scholar
• WilkinsonTMDonaldsonGCJohnstonSLOpenshawPJWedzichaJARespiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200617387187616456141
   PubMed Web of Science ®Google Scholar
• FalseyARFormicaMAHennesseyPACriddleMMSullenderWMWalshEEDetection of respiratory syncytial virus in adults with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200617363964316387798
   PubMed Web of Science ®Google Scholar
• BorgIRohdeGLosekeSEvaluation of a quantitative real- time PCR for the detection of respiratory syncytial virus in pulmonary diseasesEur Respir J20032194495112797486
   PubMed Web of Science ®Google Scholar
• SikkelMBQuintJKMalliaPWedzichaJAJohnstonSLRespiratory syncytial virus persistence in chronic obstructive pulmonary diseasePediatr Infect Dis J200827S637018820581
   PubMed Web of Science ®Google Scholar
• MatsuseTHayashiSKuwanoKKeuneckeHJefferiesWAHoggJCLatent adenoviral infection in the pathogenesis of chronic airways obstructionAm Rev Respir Dis19921461771841626800
   PubMed Web of Science ®Google Scholar
• MeshiBVitalisTZIonescuDEmphysematous lung destruction by cigarette smoke. The effects of latent adenoviral infection on the lung inflammatory responseAm J Respir Cell Mol Biol200226525711751203
   PubMed Web of Science ®Google Scholar
• McManusTEMarleyAMBaxterNAcute and latent adenovirus in COPDRespir Med20071012084209017631991
   PubMed Web of Science ®Google Scholar
• AaronSDAngelJBLunauMGranulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116334935511179105
   PubMed Web of Science ®Google Scholar
• FujimotoKYasuoMUrushibataKHanaokaMKoizumiTKuboKAirway inflammation during stable and acutely exacerbated chronic obstructive pulmonary diseaseEur Respir J20052564064615802337
   PubMed Web of Science ®Google Scholar
• PereraWRHurstJRWilkinsonTMInflammatory changes, recovery and recurrence at COPD exacerbationEur Respir J20072952753417107990
   PubMed Web of Science ®Google Scholar
• GompertzSO’BrienCBayleyDLHillSLStockleyRAChanges in bronchial inflammation during acute exacerbations of chronic bronchitisEur Respir J2001171112111911491152
   PubMed Web of Science ®Google Scholar
• TsoumakidouMTzanakisNChrysofakisGSiafakasNMNitrosative stress, heme oxygenase-1 expression and airway inflammation during severe exacerbations of COPDChest20051271911191815947302
   PubMed Web of Science ®Google Scholar
• BathoornELieskerJJPostmaDSAnti-inflammatory effects of combined budesonide/formoterol in COPD exacerbationsCOPD2008528229018972276
   PubMedGoogle Scholar
• SeemungalTAHarper-OwenRBhowmikAJeffriesDJWedzichaJADetection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary diseaseEur Respir J20001667768311106212
   PubMed Web of Science ®Google Scholar
• RohdeGBorgIWiethegeAInflammatory response in acute viral exacerbations of COPDInfection20083642743318795228
   PubMed Web of Science ®Google Scholar
• QuintJKDonaldsonGCGoldringJJBaghai-RavaryRHurstJRWedzichaJASerum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPDChest201013781282219837822
   PubMed Web of Science ®Google Scholar
• StockleyRAHillATHillSLCampbellEJBronchial inflammation: its relationship to colonizing microbial load and alpha(1)-antitrypsin deficiencyChest2000117291S293S10843958
   PubMed Web of Science ®Google Scholar
• SethiSMuscarellaKEvansNKlingmanKLGrantBJMurphyTFAirway inflammation and etiology of acute exacerbations of chronic bronchitisChest20001181557156511115440
   PubMed Web of Science ®Google Scholar
• PantSWaltersEHGriffithsAWood-BakerRJohnsDPReidDWAirway inflammation and anti-protease defences rapidly improve during treatment of an acute exacerbation of COPDRespirology20091449550319645868
   PubMed Web of Science ®Google Scholar
• SonnenfeldGHudgensRWEffect of sidestream and mainstream smoke exposure on in vitro interferon-alpha/beta production by L-929 cellsCancer Res198646277927833698007
   PubMed Web of Science ®Google Scholar
• SajjanUGanesanSComstockATElastase- and LPS-exposed mice display altered responses to rhinovirus infectionAm J Physiol Lung Cell Mol Physiol2009297L931L94419748999
   PubMed Web of Science ®Google Scholar
• SchneiderDGanesanSComstockATIncreased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201018233234020395558
   PubMed Web of Science ®Google Scholar
• Di StefanoAMaestrelliPRoggeriAUpregulation of adhesion molecules in the bronchial mucosa of subjects with chronic obstructive bronchitisAm J Respir Crit Care Med19941498038107509705
   PubMed Web of Science ®Google Scholar
• PauwelsRABuistASCalverleyPMJenkinsCRHurdSSThe GOLD Scientific CommitteeGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summaryAm J Respir Crit Care Med20011631256127611316667
   PubMedGoogle Scholar
• LindenauerPKPekowPGaoSCrawfordASGutierrezBBenjaminEMQuality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med200614489490316785478
   PubMed Web of Science ®Google Scholar
• RothbergMBPekowPSLahtiMBrodyOSkiestDJLindenauerPKAntibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary diseaseJAMA20103032035204220501925
   PubMed Web of Science ®Google Scholar
• RoedeBMBresserPPrinsJMSchellevisFVerheijTJBindelsPJReduced risk of next exacerbation and mortality associated with antibiotic use in COPDEur Respir J20093328228819047316
   PubMed Web of Science ®Google Scholar
• RoedeBMBindelsPJBrouwerHJBresserPde BorgieCAPrinsJMAntibiotics and steroids for exacerbations of COPD in primary care: compliance with Dutch guidelinesBr J Gen Pract20065666266516953997
   PubMed Web of Science ®Google Scholar
• RamFSRodriguez-RoisinRGranados-NavarreteAGarcia-AymerichJBarnesNCAntibiotics for exacerbations of chronic obstructive pulmonary diseaseCochrane Database Syst Rev200619CD00440316625602
   PubMedGoogle Scholar
• DanielsJMSnijdersDde GraaffCSVlaspolderFJansenHMBoersmaWGAntibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med201018115015719875685
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med19871061962043492164
   PubMed Web of Science ®Google Scholar
• PuhanMAVollenweiderDLatshangTSteurerJSteurer-SteyCExacerbations of chronic obstructive pulmonary disease: when are antibiotics indicated? A systematic reviewRespir Res200783017407610
   PubMed Web of Science ®Google Scholar
• QuonBSGanWQSinDDContemporary management of acute exacerbations of COPD: a systematic review and metaanalysisChest200813375676618321904
   PubMed Web of Science ®Google Scholar
• StockleyRAO’BrienCPyeAHillSLRelationship of sputum color to nature and outpatient management of acute exacerbations of COPDChest20001171638164510858396
   PubMed Web of Science ®Google Scholar
• AllegraLBlasiFDianoPSputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary diseaseRespir Med20059974274715878491
   PubMed Web of Science ®Google Scholar
• TsimogianniAMPapirisSAKanavakiSPredictors of positive sputum cultures in exacerbations of chronic obstructive pulmonary diseaseRespirology2009141114112019761538
   PubMed Web of Science ®Google Scholar
• Brusse-KeizerMGGrotenhuisAJKerstjensHARelation of sputum colour to bacterial load in acute exacerbations of COPDRespir Med200910360160619027281
   PubMed Web of Science ®Google Scholar
• van der ValkPMonninkhofEvan der PalenJZielhuisGvan HerwaardenCHendrixRClinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary diseaseClin Infect Dis20043998098615472849
   PubMed Web of Science ®Google Scholar
• SolerNEsperattiMEwigSHuertaAAgustiCTorresASputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPDEur Respir J2012 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Christ-CrainMJaccard-StolzDBingisserREffect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trialLancet200436360060714987884
   PubMed Web of Science ®Google Scholar
• StolzDChrist-CrainMBingisserRAntibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin- guidance with standard therapyChest200713191917218551
   PubMed Web of Science ®Google Scholar
• RiceKLDewanNBloomfieldHEDisease management program for chronic obstructive pulmonary disease: a randomized controlled trialAm J Respir Crit Care Med201018289089620075385
   PubMed Web of Science ®Google Scholar
• BlackPStaykovaTChackoERamFSPoolePProphylactic antibiotic therapy for chronic bronchitisCochrane Database Syst Rev20031CD00410512535510
   PubMedGoogle Scholar
• SeemungalTAWilkinsonTMHurstJRPereraWRSapsfordRJWedzichaJALong-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbationsAm J Respir Crit Care Med20081781139114718723437
   PubMed Web of Science ®Google Scholar
• AlbertRKConnettJBaileyWCAzithromycin for prevention of exacerbations of COPDN Engl J Med201136568969821864166
   PubMed Web of Science ®Google Scholar
• DesaiHRichterSDoernGAntibiotic resistance in sputum isolates of Streptococcus pneumoniae in chronic obstructive pulmonary disease is related to antibiotic exposureCOPD2010733734420854048
   PubMedGoogle Scholar
• MiravitllesMMarinAMonsoEEfficacy of moxifloxacin in the treatment of bronchial colonisation in COPDEur Respir J2009341066107119386683
   PubMed Web of Science ®Google Scholar
• SethiSJonesPWTheronMSPULSE Study groupPulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trialRespir Res2010111020109213
   PubMed Web of Science ®Google Scholar
• HaydenFGHerringtonDTCoatsTLEfficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trialsClin Infect Dis2003361523153212802751
   PubMed Web of Science ®Google Scholar
• NorderHDe PalmaAMSeliskoBPicornavirus non-structural proteins as targets for new anti-virals with broad activityAntiviral Res20118920421821236302
   PubMed Web of Science ®Google Scholar
• LiebermanJAugmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting dataChest20001181480148511083705
   PubMed Web of Science ®Google Scholar
• Barros-TizonJCTorresMLBlancoIMartinezMTReduction of severe exacerbations and hospitalization-derived costs in alpha- 1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapyTher Adv Respir Dis20126677822354900
   PubMed Web of Science ®Google Scholar